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Summary
Case report: We report the unusual case of an African patient who underwent a liver biopsy for a
chronic HBV-related hepatitis, whose histological sample also unexpectedly revealed elements
diagnostic for schistosomiasis. The patient was only mildly symptomatic for the Schistosoma
infestation; stool examination confirmed the presence of parasitic eggs. Hepatitis B virus (HBV)—
schistosomiasis co-infection is particularly rare in Western countries. Only the identification of
some pathological elements atypical for HBV infection by means of step sections in the liver
biopsy sample allowed us to disclose the unsuspected diagnosis.
Conclusions: Since migratory flows have increased, the number of foreign people being referred
to our hospitals has increased. Patients coming from areas endemic for infectious diseases that
are absent in Western countries must be carefully evaluated, taking into account possible
unexpected co-infections, including in the setting of pathological studies of liver biopsies.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights
reserved.Introduction
During the last decade, the phenomenon of immigration into
Europe of large numbers of people from Africa and from the
Middle and Far East has led Western physicians to face
considerable diagnostic challenges with infective and para-
sitic diseases not endemic in our countries.
The wide use of liver biopsy in the diagnosis of chronic
viral hepatitis has led both clinicians and pathologists to take* Corresponding author. Tel.: +39 0761 339260;
fax: +39 0761 339471.
E-mail address: e.caturelli@tiscali.it (E. Caturelli).
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doi:10.1016/j.ijid.2008.04.013into account a lot of diseases that were once thought to be
unusual in the differential diagnosis.
We describe herein the case of an African patient who
underwent a liver biopsy for a chronic hepatitis B virus (HBV)-
related hepatitis, whose histological sample also unexpect-
edly revealed elements diagnostic for schistosomiasis.
Case report
A 40-year-old man originating from the Gambia and a resi-
dent in Italy for 5 years, was admitted to Belcolle Hospital for
intermittent pain, in all abdominal quadrants, accompaniedPublished by Elsevier Ltd. All rights reserved.
Figure 3 Parasitic egg (arrow) with brown shell and spine,
partially altered due to overlapping of eosinophils and macro-
phages.
Figure 1 Schistosoma egg (arrow) surrounded by eosinophils,
plasma cells, and macrophages.
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no past medical history of episode of fever consistent with
malaria infestation. He presented in good general condition,
with no significant abnormalities on abdominal examination.
Routine blood and urine tests showed no significant abnorm-
ality, except for elevated AST (102 IU/l) and ALT (163 IU/l)
serum levels (normal values: up to 46 and 56 IU/l, respec-
tively). g-Glutamyl transpeptidase and alkaline phosphatase
serum levels were in the normal range. HBV markers were as
follows: HBsAg positive, anti-HBs antibody negative, anti-
HBc IgG positive, HBeAg negative, and anti-HBe antibody
positive. Anti-hepatitis C virus (HCV) antibody was negative,
as well as anti-HIV antibody. HBV-DNA determination:
37 328 IU. Results of stool culture were negative. A colono-
scopy was performed: only a slight hyperemia of the rectal
mucosa was found, with no specific findings on histological
examination of the biopsies.
An ultrasound-guided biopsy (using a 18-G cutting needle)
was performed on the right liver lobe to establish the stage of
HBV-related liver disease. A liver sampleof 4.5 cm(fixed in10%
buffered formalin) was processed, and 5-mm step sections
were stained with hematoxylin and eosin (H&E), Gomori,Figure 2 Immunohistochemical intracytoplasmic staining for
hepatitis B surface antigen.and with immunostain for HBsAg and HBcAg. On light micro-
scopy, a mild to moderate lymphoplasmacytic infiltrate was
detected in the portal tracts, with numerous eosinophils and
macrophages forming epithelioid granulomas, sometimeswith
giant cells (Figure 1). Clumps of dark brown pigment were
evident in the portal macrophages; this pigment was birefrin-
gent under polarized light in a red—yellow color, indistinguish-
able from malarial hemozoin pigment. No significant
piecemeal necrosis or lobular activity was present (grade 2,
according to Ishak et al.).1 The liver architecture was pre-
served; most of the portal tracts were enlarged, but no septae
extended far into the lobule, nor were areas of bridging
evident (stage 2, according to Ishak et al.).
Immunohistochemical staining showed the presence of
HBsAg in the cytoplasm of 30% of the liver cells (Figure 2),
while HBcAg was not detected. The presence of a large
number of eosinophils in the portal tracts, epithelioid gran-
ulomas, and hemozoin pigment are not characteristic of HBV
infection, but rather suggest a diagnosis of malaria or schis-
tosomiasis. Step sections showed foreign material with the
appearance of parasitic eggs within the granulomas (Figures 1
and 3), with brown shell and spine and a circular ring of
nuclei, reminiscent of Schistosoma.
At this point, a parasitologic examination identified Schis-
tosoma mansoni eggs in the stools. Treatment to eradicate
the parasite was administered orally: praziquantel, 40 mg/kg
in two doses over a single day. Symptoms improved within a
week. A repeat parasitologic stool examination, performed
after onemonth, was negative for Schistosomamansoni eggs.
Due to the elevated AST and ALT serum levels, the high
titer of HBV-DNA, the HBV marker serology (anti-HBe posi-
tivity), and the mild necroinflammation activity, the patient
was given oral anti-viral treatment with entecavir, 1 mg
daily. This dosage was chosen because of the presence of a
high viral load. The patient was not pretreated with lami-
vudine. After a 5-month antiviral therapy, the viral load was
negative. The patient is still taking entecavir.
Discussion
Liver biopsy is indicated in the diagnosis of a wide range of
hepatic diseases, among which chronic viral hepatitis has an
Liver schistosomiasis e69important place.2 When nothing more than abnormal liver
biochemistry is present, a liver biopsy may reveal a wide
range of hepatic diseases of assorted nature and extent.3
The possibility of a liver biopsy revealing an unsus-
pected secondary pathology or an alternative diagnosis
is well known; this is reported to range from 2.4% to
3.7%.4,5 More frequently, such unexpected findings consist
of fatty liver disease, iron overload, and intra-hepatic
cholestasis.4,5 In our patient, the liver biopsy was only
performed in order to grade and stage the HBV-related
chronic liver disease suspected on the basis of serological
findings. But the inflammatory infiltrate detected in the
portal tracts was not characteristic of HBV-related chronic
hepatitis, nor was the dark brown pigment present in
macrophages and Kupffer cells, which suggested different
diagnostic hypotheses such as malaria or schistosomiasis.
The malaria hypothesis, even of the low-grade falciparum
type, was excluded since the patient had lived perma-
nently in Italy for many years, never traveling abroad.
Accordingly, a thick and thin blood smear was not per-
formed. It is known that when malaria parasitemia sub-
sides, the hemozoin pigment shifts to the portal tract
macrophages and is subsequently cleared after a variable
time-period.6 The hypothesis of a malaria infestation
occurring before the patient’s immigration to Italy was
also excluded, because of the absence of any significant
fever episode in the anamnesis. The provenance of the
patient from tropical Africa, a region endemic for various
parasitic diseases, prompted pathologists to perform step
sections on the liver biopsy sample to search for elements
suggestive of other infestations. In this way, elements
typical of a diagnosis of schistosomiasis were found,
besides the findings of chronic HBV hepatitis. This co-
infection is considered very unusual in our health units,
since it is not mentioned in any of the recent surveys on
this topic.3—5
Schistosomiasis is a parasitic infestation caused by flat-
worms localized mainly in the gut (Schistosoma mansoni,
Schistosoma mekongi, Schistosoma japonicum) and in the
genitourinary tract (Schistosoma haematobium). This dis-
ease is endemic in 74 African, South American, Caribbean,
and Asian countries. According to the World Health Orga-
nization, approximately 200 million people are infested
worldwide.7 Human infection is initiated when cercariae
penetrate intact skin during immersion in fresh water
where infected snails live. The organism begins its trans-
formation, and migrates through the venous or lymphatic
vessels to the lungs and to the intestine. Most of these
infestations, if symptomatic, cause abdominal pain and
diarrhea. In some Schistosoma cases with intestinal invol-
vement (about 25—50%, particularly in hyperendemic
areas), the eggs pass into the portal circulation. They
are trapped in the portal tracts, causing a granulomatous
inflammatory response inducing perisinusoidal inflamma-
tion and periportal fibrosis.
In endemic countries the Schistosoma—HBV co-infection
is well known. In a population of HBsAg-positive blood
donors in Brazil,8 35.5% of patients had schistosomiasis
elements in their liver biopsy samples. An interaction
between schistosomiasis and viral hepatitis B has often
been suggested, but controversial data are present in
the literature. The reciprocal influence of these two dis-eases has not yet been definitively established, even in
experimental animal models,9 in which the two diseases
seem to run parallel courses. Also, a lack of interaction with
schistosomiasis has been found in patients with HCV-related
hepatitis, whose histological scores do not differ according
to the presence or the absence of schistosomal infection.10
Some studies conducted in the Far East in order to verify
the hypothesis of a role of Schistosoma japonicum infesta-
tion in the development of hepatocellular carcinoma (HCC)
in HBV patients, have tended to exclude this possibility.11,12
Rather, it would be the complication with HBV infection
(through chronic hepatitis and liver cirrhosis) that repre-
sents the major factor involved in the development of HCC
in patients infested with Schistosoma japonica. On the
other hand, there are several reports indicating that HBV
or HCV and Schistosoma mansoni co-infections are asso-
ciated with accelerated deterioration of hepatic function
and a higher risk of HCC than that attributable to HBV
alone.13,14 An explanation for these discrepancies could be
either in the different activities or in the various popula-
tions of the virus-related hepatitis, or the number or
reinfestations due to Schistosoma. In our patient, for exam-
ple, the damage likely due to HBV-related hepatitis was
limited (grade 2, stage 2), and the inflammatory reaction to
Schistosoma infestation was circumscribed around the
eggs, probably due to the absence of reinfestations (since
he had lived for a long time in Italy). No interference on
safety and immunogenicity of a recombinant hepatitis B
vaccine has been reported in Egypt in patients affected
with Schistosoma mansoni.15
In Western countries, where snails representing the inter-
mediate hosts of schistosomiasis do not live, no native case is
possible, and such a disease is considered very uncommon. All
detected cases are imported by tourists who have traveled in
endemic areas or by people who have immigrated from such
countries. Migratory flows have especially increased the
number of foreign people being referred to our hospitals.
Hence, patients coming from areas endemic for infectious
diseases that are absent in Western countries must be care-
fully evaluated, taking into account possible unexpected co-
infections, including in the setting of the interpretation of
liver biopsies. Western pathologists may be not completely
confident with the diagnosis of schistosomiasis because of its
rarity. A thoughtful approach to liver biopsy interpretation
when uncharacteristic elements are found may suggest dif-
ferent hypotheses, allowing the correct diagnosis to be
established.
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